Home/Filings/4/0001062993-22-019835
4//SEC Filing

McKesson Ventures, LLC 4

Accession 0001062993-22-019835

CIK 0001769804other

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 8:05 AM ET

Size

8.7 KB

Accession

0001062993-22-019835

Insider Transaction Report

Form 4
Period: 2022-09-19
McKesson Ventures, LLC
Director10% Owner
Transactions
  • Sale

    Common Stock

    2022-09-19$2.18/sh3,900$8,5024,043,706 total
  • Sale

    Common Stock

    2022-09-20$2.02/sh2,500$5,0504,041,206 total
  • Sale

    Common Stock

    2022-09-21$1.92/sh720$1,3824,040,486 total
Footnotes (3)
  • [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.08 to $2.44. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.92 to $2.10. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.87 to $2.03. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Augmedix, Inc.

CIK 0001769804

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001827312

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 8:05 AM ET
Size
8.7 KB